lobbying_activities: 2634708

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2634708	1743993d-d55b-47d0-9173-e07325a21413	Q2	340B HEALTH	316434	340B HEALTH	2021	second_quarter	PHA	The 340B Drug Pricing Program; S.773 - A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes; H.R. 853: Closing Loopholes for Orphan Drugs Act; H.R.3203 - To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes; H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act; H.R.19 - Lower Costs, More Cures Act of 2021;	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE		272268	0	0	2021-07-09T14:42:00.983000-04:00